請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58640
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 張國柱 | |
dc.contributor.author | Ya-Hui Ko | en |
dc.contributor.author | 柯雅惠 | zh_TW |
dc.date.accessioned | 2021-06-16T08:23:29Z | - |
dc.date.available | 2014-02-25 | |
dc.date.copyright | 2014-02-25 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-01-23 | |
dc.identifier.citation | Aderem A, and Ulevitch RJ (2000). Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787.
Akira S, and Hemmi H (2003). Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85: 85-95. Andreasen AS, Krabbe KS, Krogh-Madsen R, Taudorf S, Pedersen BK, Moller (2008). Human endotoxemia as a model of systemic inflammation. Curr Med Chem 15: 1697-1705. Annane D, Bellissant E, Cavaillon JM (2005). Septic shock. Lancet 365:63-78. Azevedo LCP, Janiszewski M, Soriano FG, Laurindo FRM (2006). Redox mechanisms of vascular cell dysfunction in sepsis. Endocrine, Metabolic & Immune Disorders Drug Targets 6: 159-164. Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, De Caterina R (2002). Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105:816-822. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990). Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87: 1620-1624. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP (2005). Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83: 876-886. Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol 2:907-916. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RMH, and Sibbald WJ (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101(6): 1644-1655. Boyle WA 3rd, Parvathaneni LS, Bourlier V, Sauter C, Laubach VE, Cobb JP (2000). iNOS gene expression modulates microvascular responsiveness in. Circ Res 87:E18-E24. Brownlee M, Cerami A, Vlassara H (1988). Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321. Bucala R, Tracey KJ, Cerami A (1991). Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438. Burattini R, Fioretti S, Jetto L (1985). A simple algorithm for defining the mean cardiac cycle of aortic flow and pressure during steady state. Comput Biomed Res 18(4): 303-312. Colasanti M, and Suzuki H (2000). The dual personality of NO. Trends Pharmacpl Sci 21: 249-252. Cox RH (1974). Three-dimensional mechanics of arterial segments in vitro methods. J Appl Physiol 36: 381–384. Crouser E, Exline M, Knoell D, Wewers MD (2008). Sepsis: links between pathogen sensing and organ damage. Curr Pharm Design 14: 1840-1852. Dandona P, Aljada A, Chaudhuri A, Mohanty P, and Garg R (2005). Metabolic syndrome - A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111(11): 1448-1454. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, and Gudnason V (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350(14): 1387-1397. Didierlaurent A, Brissoni B, Velin D, Aebi N, Tardivel A, Kaslin E, Sirard JC, Angelov G, Tschopp J, and Burns K (2006). Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol Cell Biol 26: 735-742. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL (2001). Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 37:554-560. Eckersal PD (2000). Recent advances and future prospects for the use of acute phase proteins and markers of disease in animals. Revue Med Vet 151: 577-587. Geetha C, Venkatesh SG, Bingle L, Bingle CD, and Gorr SU (2005). Design and validation of anti inflammatory peptides from human parotid secretory protein. J Dent Res.84:149-153. Grissom TE, Bina S, Hart J, and Muldoon SM (1996). Effect of halothane on phenylephrine-induced vascular smooth muscle contractions in endotoxin-exposed rat aortic rings. Crit Care Med 24: 287-293. Guyton AC (1992). Kidneys and fluids in pressure regulation - small volume but large pressure changes. Hypertension 19: I2-8. Hall S, Turcato S, and Clapp L (1996). Abnormal activation of K+ channels underlies relaxation to bacterial lipopolysaccharide in rat aorta. Biochem Biophys Res Commun 224(1): 184-190. Hamalainen M, Lilja R, Kankaanranta H, Moilanen E (2008). Inhibition of iNOS expression and NO production by anti-inflammatory steroids. Reversal by histone deacetylase inhibitors. Pulm Pharmacol Ther 21: 331-339. Hollenberg SM, Cunnion RE, Cunnion RE, and Zimmerberg J (1993). Nitric-oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 264(2): H660-H663. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, and Akira S (1999). Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752. Kleinert H, Pautz A, Linker K, and Schwarz PM (2004). Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 500: 255-266. Ko YH, Tsai MS, Lee PH, Liang JT, Chang KC (2013). Methylprednisolone stiffens aortas in lipopolysaccharide-induced chronic inflammation in rats. PLOS ONE 8(7): e69636. Krumenacker JS, Hanafy KA, and Murad F (2004). Regulation of nitric oxide and soluble guanylyl cyclase. Brain Res Bull 62(6): 505-515. Laxminarayan S, Sipkema P, Westerhof N (1978). Characterization of the arterial system in the time domain. IEEE Trans Biomed Eng 25: 177-184. Leon CG, Tory R, Jia J, Sivak O, Wasan KM (2008). Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharmaceutical Res 25: 1751-1761. Li JF, Schmidt AM (1997). Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 272: 16498-16506. Liu A, Brin KP, Yin FCP (1986). Estimation of total arterial compliance: An improved method and evaluation of current methods. Am J Physiol 251 (Heart Circ Physiol 20): H588-H600. Lopez AD, Mathers CD, Ezzati M, Jamison DT, and Murray CJL (2006). Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367(9524): 1747-1757. Milnor WR (1975). Arterial impedance as ventricular afterload. Circ Res 36(5): 565-570. Milnor WR (1989). Hemodynamics. Baltimore: Williams & Wilkins Co. Mitchell GF, Pfeffer MA, Westerhof N, Pfeffer JM (1994). Measurement of aortic input impedance in rats. Am J Physiol 267 (Heart Circ Physiol 36): H1907-1915. Miyoshi H, and Nakaya Y (1994). Endotoxin-induced nonendothelial nitric oxide activates the Ca2+-activated K+ channel in cultured vascular smooth muscle cells. J Mol Cell Cardiol 26(11): 1487-1495. Mullarkey CJ, Edelstein D, Brownlee M (1990). Free-radical generation by early glycation products - a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173: 932-939. Nichols WW, Conti CR, Walker WE, Milnor WR (1977). Input impedance of the systemic circulation in man. Circ Res 40(5): 451-458. Nichols WW, O’Rourke MF (2005) McDonald’s blood flow in arteries. London: Arnold. Nichols WW, Pepine CJ, Geiser EA, Conti CR (1980). Vascular load defined by the aortic input impedance spectrum. Fed Proc 39(2): 196-201. Nims RW, Cook JC, Krishna MC, Christodoulou D, Poore CM, Miles AM, Grisham MB, Wink DA (1996). Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol 268: 93-105. Noble M, Gade I, Frenchard D (1976). Blood pressure and flow in the ascending aorta of conscious dogs. Cardiovasc Res 1: 9-21. Pepine CJ, Nichols WW (1982). Aortic input impedance in cardiovascular disease. Prog Cardiovasc Dis 24(4): 307-318. Perry VH (2004). The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 18(5): 407-413. Peters M, Muller AM, and Rose-John S (1998). Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood 92:3495-3504. Raetz CRH, Ulevitch RJ, Wright SD, Sibley CH, Ding AH, and Nathan CF (1991). Gram-negative endotoxin- an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB Journal 5(12): 2652-2660. Raetz CRH, Whitfield C (2002). Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700. Riccardi C, Bruscoli S, Migliorati G (2002). Molecular mechanisms of immunomodulatory activity of glucocorticoids. Pharmacol Res 45:361-368. Ridker PM, Hennekens CH, Buring JE, and Rifai N (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342(12): 836-843. Ross J, Covell J, Sonnenbuck E, Braunwald E (1996). Contractile state of the heart characterized by force-velocity relations in variable afterload and isovolumic beats. Cardiovasc Res 18: 149-163. Ross R (1999). Mechanisms of disease - Atherosclerosis - An inflammatory disease. N Engl J Med 340(2): 115-126. Schultz MJ, van der Poll T (2002). Animal and human models for sepsis. Ann Med 34: 573-581. Sellebjerg F, Giovannoni G, Hand A, Madsen HO, Jensen CV, Garred P (2002). Cerebrospinal fluid levels of nitric oxide metabolites predict response to methylprednisolone treatment in multiple sclerosis and optic neuritis. J Neuroimmunol 125: 198-203. Sennoun N, Baron-Menguy C, Burban M, Lecompte T, Andriantsitohaina R, Henrion D, Mercat A, Asfar P, Levy B, and Meziani F (2009). Recombinant human activated protein C improves endotoxemia-induced endothelial dysfunction: a blood-free model in isolated mouse arteries. Am J Physiol Heart Circ Physiol 297: H277-H282. Shoelson SE, Lee J, and Goldfine AB (2006). Inflammation and insulin resistance. J Clin Invest 116(7): 1793-1801. Singh R, Barden A, Mori T, Beilin L (2001). Advanced glycation end-products: a review. Diabetologia 44:129-146. Sipkema P, Westerhof N, Randall OS (1980). The arterial system characterised in the time domain. Cardiovasc Res 14:270-279. Smith BJ, Lightfoot SA, Lerner MR, Denson KD, Morgan DL, Hanas JS, Bronze MS, Postier RG, and Brackett DJ (2009). Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation. Cardiovascular Pathology 18: 1-10. Snyder T, Bredt A (1992). Biological roles of nitric oxide. Sci Am 5:68-77. Stannard SR, and Johnson NA (2006). Energy well spent fighting the diabetes epidemic. Diabetes Metab Res Rev 22(1): 11-19. Stoll LL, Denning GM, Weintraub NL (2004). Potential role of endotoxin as a proinflammatory mediators of atherosclerosis. Arterioscler Thromb Vascu Biol 24: 2227-2236. Tedgui A, and Mallat Z (2006). Cytokines in atherosclerosis: Pathogenic and regulatory pathways. Physiol Rev 86(2): 515-581. Theeuwes F and Yum SI (1976). Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug ormulations. Ann Biomed Eng 4(4): 343-353. Verma S, Devaraj S, and Jialal I (2006). C-reactive protein promotes atherothrombosis. Circulation 113: 2135-2150. Wautier MP, Chappey O, Corda S, Stern DM, Schimidt AM, and Wautier JL (2001). Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280: E685-E694. Wellen KE, and Hotamisligil GS (2005). Inflammation, stress, and diabetes. J Clin Invest 115(5): 1111-1119. Westerhof N, Sipkema P, Vanden Bos GC, Elzinga G (1972). Forward and backward waves in the arterial system. Cardiovasc Res 6: 648-656. Xu J, Fan G, Chen S, Wu Y, Xu XM, Hsu CY (1998). Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. Brain Res Mol Brain Res 59:135-142. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S, and Harris T (2003). Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61(1): 76-80. Yan SD, Schmidt AM, Anderson GM, Zhang JH, Brett J, Zou YS, Pinsky D, and Stern D (1994). Enhanced cellular oxidant stress by the interaction of advanced glycation end-products with their receptors binding proteins. J Biol Chem 269: 9889-9897. Zhong Y, Li SH, Liu SM, Szmitko PE, He XQ, Fedak PWM, Verma S (2006). C-reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension 48: 504-511. Zuckerman SH, Shellhaas J, Butler LD (1989). Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 19:301-305. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58640 | - |
dc.description.abstract | 研究背景與目的:具研究顯示,由內毒素如脂多醣(lipopolysaccharide, LPS)所引起的系統性發炎疾病與心血管疾病發生有關。醣皮質醇(glucocorticoids)是一種普遍用以治療急性或慢性發炎,以及自體免疫疾病的藥物。本篇研究利用脂多醣誘發慢性發炎的雄性Wistar大鼠以探討methylprednisolone(MP,一種合成的醣皮質醇類藥物)對動物動脈管延展性與血管阻力方面的影響。
研究材料與方法:本研究將LPS注入ALZET微型滲透幫浦膠囊並埋入雄性Wistar大鼠右下腹部皮下,每日釋放每公斤體重1毫克LPS,藉由皮下微血管吸收來誘發大鼠產生慢性發炎,LPS處理時間分別為二週及四週。隨機將雄性Wistar大鼠分為三組:(1)假手術組(sham group);(2)LPS誘發慢性發炎疾病組(LPS group);(3)LPS誘發慢性發炎合併給予MP治療組(LPS-MP group),其中MP的給藥劑量與方式為利用腹腔注射方式給予每天每公斤體重5毫克。在第二週及第四週時,進行右頸動脈插管及開胸手術,測量心電圖、主動脈血壓及血流訊號,訊號經由傅立葉轉換後用以分析主動脈輸入阻抗頻譜,並得到描述動脈管彈性的波反射時間(τ)及其它動脈管物理特性參數。實驗後採集血液樣本進行血漿中C反應蛋白(CRP)、介白素-6(IL-6)、一氧化氮(NO)及過氧化亞硝酸鹽(peroxynitrite)的含量分析。利用西方點墨法及組織免疫染色,測量主動脈蛋白質的表現。 研究結果:在脂多醣誘發慢性發炎的疾病組大鼠上發現動脈管總週邊阻力(Rp)下降,血管舒張的情形。此外,動脈管順應性的增加並無伴隨動脈管延展性的改變,顯示在慢性發炎大鼠體內有全身血液容積擴張之現象。研究發現長期給予脂多醣處理的大鼠,主動脈管中蓄積較多的最終糖化終產物(AGEs)及誘導型一氧化氮合成酶(iNOS),結果產生過量的一氧化氮而造成血管舒張。然而經由計算波反射時間(τ)結果顯示給予脂多醣處理的大鼠,對主動脈管的彈性並無任何影響,推論是產生過多一氧化氮抵消了最終糖化終產物對血管硬化效應,而使動脈管延展性不受絲毫影響。此外,在LPS誘發慢性發炎合併給予MP治療組中發現,雖然動脈管總週邊阻力(Rp)增加,改善周邊血管舒張現象,但減少波反射時間(τ),顯示MP治療組大鼠主動脈管發生硬化。據研究結果顯示MP治療組大鼠血漿中一氧化氮減少,但主動脈管最終糖化終產物並無顯著下降,可能是導致MP治療組大鼠動脈管延展性變差發生硬化之原因。 結論:在脂多醣誘發慢性發炎的大鼠上若給予methylprednisolone治療,將使主動脈管產生硬化,而在這過程中一氧化氮含量對最終糖化終產物致使主動脈管產生硬化具有關鍵性的影響。 | zh_TW |
dc.description.abstract | Background and purpose: It has been shown that systemic inflammation exerted by endotoxins such as lipopolysaccharide (LPS) is associated with cardiovascular diseases. Glucocorticoids are commonly used as therapeutic agents in many acute and chronic inflammatory and autoimmune diseases. The current study investigated the effects of methylprednisolone (a synthetic glucocorticoid) on aortic distensibility and vascular resistance in LPS-induced chronic inflammation in male Wistar rats.
Material and methods: Chronic inflammation was induced by implanting a subcutaneous slow-release ALZET osmotic pump (1 mg/kg/day LPS) for either 2 or 4 weeks. Animals are randomized into three groups: 1) sham, 2) LPS, 3) LPS treated with methylprednisolone (5 mg/kg/day i.p.). Pulsatile aortic pressure and flow signals were measured at different time points, and then were subjected to Fourier transformation for the analysis of aortic input impedance. Arterial wave transit time (τ) was derived to describe the elastic properties of aortas using the impulse response function of the filtered aortic input impedance spectra. At the end of catheterization, blood sample from the animals studied were collected for determination of plasma levels of C-reactive protein (CRP), interleukin-6 (IL-6), nitric oxide (NOx), and peroxynitrite. The aortic protein expression was examined by Western blot and immunohistochemistry. Results: Vasodilatation occurred in the LPS-infused rats, as evidenced by the fall in total peripheral resistance (Rp). Moreover, an increase in arterial compliance, but lacking of significant changes in aortic distensibility suggested that volume expansion may occur in the animals administered LPS. Long-term LPS challenge enhanced the expression of advanced glycation end products (AGEs) in the aortas. LPS also upregulated the inducible form of nitric oxide synthase (iNOS) to produce high levels of nitric oxide (NO), which resulted in vasodilation. However, LPS challenge did not influence the elastic properties of aortas, as shown by the unaltered τ. The NO-mediated vascular relaxation may counterbalance the AGEs-induced arterial stiffening so that the aortic distensibility remained unaltered. Treating LPS-challenged rats with methylprednisolone prevented peripheral vasodilation, as indicated by increased Rp. However, methylprednisolone produced an increase in aorta stiffness, as manifested by the significant decline inτ. The diminished aortic distensibility by methylprednisolone paralleled a significant reduction in NO plasma levels, in the absence of any significant changes in AGEs content. Conclusion: Methylprednisolone stiffens aortas and elastic arteries in LPS-induced chronic inflammation in rats, for NO activity may be dominant as a counteraction of AGEs. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T08:23:29Z (GMT). No. of bitstreams: 1 ntu-103-D94441002-1.pdf: 1730223 bytes, checksum: c7541ad985e8caea69dfeda971ce91b0 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 目錄 ii
中文摘要 v 英文摘要(Abstract) vii 縮寫名詞對照表 ix 表次 xi 圖次 xi 文獻回顧 1 一、發炎與疾病 1 二、脂多醣誘發全身性系統發炎反應 2 三、脂多醣對心血管系統的侵害 3 3-1 經由與最終糖化終產物接受器結合之機制 3 3-2 經由與誘導型一氧化氮合成酶作用之機制 3 四、脂多醣誘發大鼠慢性發炎的動物模式 5 五、Methylprednisolone的藥理作用 5 六、動脈物理性質的量化 6 6-1 主動脈輸入阻抗頻譜的特性及功能 6 研究目的 9 材料與方法 10 一、實驗動物製備 10 二、使用ALZET微型滲透幫浦膠囊協助慢性發炎動物模式之建立 10 三、實驗動物分組 11 四、實驗儀器介紹 12 4-1 壓力感應器(pressure sensor) 12 4-2 電磁感應血流計(electromagnetic flowmeter) 12 五、實驗流程 13 六、左心室比率 14 七、資料轉換與分析方法 15 7-1 平均週期運算法則(mean cycle algorithm) 15 7-2 時序校正(timing correction) 16 7-3 血行力學參數之計算與分析 16 7-3-1 主動脈輸入阻抗頻譜(aortic input impedance spectra) 16 7-3-2 動脈容積度(arterial compliance, Cm) 19 7-3-3 前進波、反射波與波反射係數(wave reflection factor, Rf)推算 19 7-3-4 波傳輸時間(wave transit time, τ)的推算 20 八、生化物質檢測 21 8-1 血漿中脂多醣結合蛋白(LBP)、一氧化氮(NO)、過氧化亞硝酸鹽21 8-2 主動脈管誘導型一氧化氮合成酶(iNOS)蛋白表現之組織免疫螢光染色(immunofluorescence staining)分析 22 8-3 主動脈管第四型Toll-like接受器(TLR4)、最終糖化終產物(AGEs)及最終糖化終產物接受器(RAGE)蛋白表現之組織免疫染色(immunohistochemical staining)分析 23 8-4主動脈管誘導型一氧化氮合成酶(iNOS)、最終糖化終產物(AGEs)及最終糖化終產物接受器(RAGE)蛋白表現含量之西方墨點法(Western blot)分析 24 九、統計方法 26 結果 27 一、脂多醣誘發慢性發炎大鼠動物模式之建立 27 二、基本生理參數 28 三、主動脈中最終糖化終產物(AGEs)、最終糖化終產物接受器 (RAGE)及誘導型一氧化氮合成酶(iNOS)蛋白表現 29 四、血漿中生化物質 31 五、穩態血行力學參數 32 六、脈態血行力學參數 33 結果摘要…………………………………………………………………………………………..…..……………34 討論 35 一、脂多醣對阻力型血管-周邊小動脈物理特性之影響 36 二、脂多醣對彈力型血管-大動脈管物理特性之影響 38 三、MP、NO與AGEs之間的交互作用對脂多醣誘發慢性發炎狀態 下的心血管功能改變之情形 39 研究限制 41 結論 42 附錄………………………………….………………………………….43 未來研究方向…………………………………………………………..44 結果圖表………………………………………………………………..45 參考文獻 ……………………………………………………………..54 | |
dc.language.iso | zh-TW | |
dc.title | Methylprednisolone對lipopolysaccharide所誘發慢性發炎大鼠之動脈系統物理性質的影響 | zh_TW |
dc.title | Effects of methylprednisolone on mechanical properties of arterial system in lipopolysaccharide-induced chronic inflammatory rats | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 李伯皇,梁金銅,王水深,陳益祥,蔡明憲 | |
dc.subject.keyword | 最終糖化終產物,主動脈輸入阻抗頻譜,波傳輸時間,一氧化氮, | zh_TW |
dc.subject.keyword | advanced glycation end products,aortic input impedance spectra,arterial wave transit time,nitric oxide, | en |
dc.relation.page | 62 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-01-24 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 生理學研究所 | zh_TW |
顯示於系所單位: | 生理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 1.69 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。